These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3376180)

  • 1. Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?
    Johno I; Kuzuya T; Suzuki K; Hasegawa M; Nakamura T; Kitazawa S; Aso K; Watanabe K
    Ther Drug Monit; 1988; 10(1):39-44. PubMed ID: 3376180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical value of free phenytoin levels.
    Theodore WH; Yu L; Price B; Yonekawa W; Porter RJ; Kapetanovic I; Moore H; Kupferberg H
    Ann Neurol; 1985 Jul; 18(1):90-3. PubMed ID: 4037755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid-phenytoin interaction.
    Friel PN; Leal KW; Wilensky AJ
    Ther Drug Monit; 1979; 1(2):243-8. PubMed ID: 122160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA; Mattson RH
    Ther Drug Monit; 1979; 1(1):105-16. PubMed ID: 121944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding parameters of phenytoin during monotherapy and polytherapy.
    Pospísil J; Perlík F
    Int J Clin Pharmacol Ther Toxicol; 1992 Jan; 30(1):24-8. PubMed ID: 1348053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free phenytoin monitoring in serum and saliva of epileptic patients in China.
    Cai WM; Zhu GZ; Chen G
    Ther Drug Monit; 1993 Feb; 15(1):31-4. PubMed ID: 8451777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
    Irshaid YM; Hamdi AA; Al Homrany M
    Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of non-linear relationship between total and unbound serum concentrations of valproic acid in epileptic children.
    Ueshima S; Aiba T; Makita T; Nishihara S; Kitamura Y; Kurosaki Y; Kawasaki H; Sendo T; Ohtsuka Y; Gomita Y
    J Clin Pharm Ther; 2008 Feb; 33(1):31-8. PubMed ID: 18211614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of binding equation method for prediction of unbound serum valproic acid concentration in pediatric patients with epilepsy.
    Kodama Y; Kuranari M; Kodama H; Koike Y; Yasunaga F; Fujii I; Takeyama M
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):114-8. PubMed ID: 7757310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total phenytoin concentrations do not accurately predict free phenytoin concentrations in critically ill children.
    Wolf GK; McClain CD; Zurakowski D; Dodson B; McManus ML
    Pediatr Crit Care Med; 2006 Sep; 7(5):434-9; quiz 440. PubMed ID: 16885794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of plasma free phenytoin measurement and factors influencing its protein binding.
    Iwamoto T; Kagawa Y; Naito Y; Kuzuhara S; Okuda M
    Biopharm Drug Dispos; 2006 Mar; 27(2):77-84. PubMed ID: 16308884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo determination of valproate binding constants during sole and multi-drug therapy.
    Scheyer RD; Cramer JA; Toftness BR; Hochholzer JM; Mattson RH
    Ther Drug Monit; 1990 Mar; 12(2):117-23. PubMed ID: 2107606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations and enzyme induction in epileptic children treated with phenytoin and valproate.
    de Wolff FA; Peters AC; van Kempen GM
    Neuropediatrics; 1982 Feb; 13(1):10-3. PubMed ID: 6123089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictability of unbound antiepileptic drug concentrations in children treated with valproic acid and phenytoin.
    Miles MV; Snead OC; Thorn MD
    Clin Pharm; 1988 Sep; 7(9):688-93. PubMed ID: 3149223
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM; Wolff DL; Graves NM
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.